Nelson Capital assists the growth of companies on a shared equity basis

<body bgcolor="white"> <table border="0" cellpadding="0" cellspacing="0" width="500"> <tr> <td width="106"> <img src="../etc/spacer.gif" width="106"> </td> <td> <br /> <center><img src="gfx/h01.gif" width="258" height="17" alt="Corporate History" border="0"></center> <br /><br /> <p>Nelson Capital was established in 1998 by Senior Partners, Anthony Short and Justin Birchmore, as a mechanism to formalise and pool their respective deal flows. Formed under the true principles of merchant banking, the firm aims to contribute towards the growth of companies on a shared equity, often success fee, basis. </p> <p> An early example of this approach is evidenced by the paper acquisition of RAMA Technologies Pty Ltd (now operating under the name of Willhart Technologies) by Willhart Limited. By arranging this acquisition, Nelson Capital received a success-based equity fee outlined in a non-exclusive RAMA mandate calling for better access to capital markets. No retainer fee was charged. Through Willhart, a listed company on the Australian Stock Exchange, that access has been achieved and the Company is now able to promote and market its unique telecommunications technology product set on a global basis.</p> <p> Nelson Capital is also capable of driving new initiatives from a principal investment perspective. This is evidenced by the formation of Biomedical Investments Limited; a public Australian company in which Nelson Capital owns majority equity. The company seeks to assist in the commercialisation of biomedical R&D product through the contribution of corporate skills, global contacts and access to capital. It in turn instigated the inception of and holds a significant equity position in Oral Health Care Limited, which has secured access to unique, sector specific therapeutic product for wholesale distribution. </p> <p> The Partnership more recently established a majority owned subsidiary by the name of Global Water Resources Pty Ltd, which seeks to identify proprietary opportunities addressing water provision and water quality difficulties recognised on a global level. By way of example, the Company has secured a 20% interest in Zerolet Pty Ltd (which possesses secured regional rights to a waste water management product) and success-fee sourced options in Solar Sustain Pty Ltd (a company with a patented system for the desalinisation of water through a solar-thermal process) by facilitating capital investment therein. </p> <p> The principals of Nelson Capital also represent the majority interest in a start-up plant tissue culture laboratory by the name of TechGro Limited, which utilises leading edge biotechnology methods to mass-propagate clonally identical plants from the cell level. TechGro is also actively pursuing lines of dialogue in respect of relevant R&D programs where intellectual property of commercial value can be developed. </p> <p> Nelson Capital also seeks to provide The Nelson Foundation with a modest free-carried equity interest in each of the 'in-principle' projects the firm becomes involved in. Once in a position of sufficient financial capacity, it's independent Board will endeavour to identify projects of a purely humanitarian and non-commercial nature as the recipient of charitable funding.<br /><br /><br /> </p> </td> </tr> </table> </body>